Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 Jun;152(6):1433–1443.

Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

F Samaniego 1, P D Markham 1, R Gendelman 1, Y Watanabe 1, V Kao 1, K Kowalski 1, J A Sonnabend 1, A Pintus 1, R C Gallo 1, B Ensoli 1
PMCID: PMC1858461  PMID: 9626048

Abstract

All forms of Kaposi's sarcoma (KS) are characterized by spindle cell proliferation, angiogenesis, inflammatory cell infiltration, and edema. We have previously reported that spindle cells of primary KS lesions and KS-derived spindle cell cultures express high levels of basic fibroblast growth factor (bFGF), which is promoted by the inflammatory cytokines identified in these lesions. These cytokines, namely, tumor necrosis factor, interleukin-1, and interferon-gamma, induce production and release of bFGF, which stimulates angiogenesis and spindle cell growth in an autocrine fashion. Here we show that both AIDS-KS and classical KS lesions co-express vascular endothelial growth factor (VEGF) and bFGF. VEGF production by KS cells is promoted synergistically by inflammatory cytokines present in conditioned media from activated T cells and in KS lesions. KS cells show synthesis of VEGF isoforms that are mitogenic to endothelial cells but not to KS spindle cells, suggesting a prevailing paracrine effect of this cytokine. This may be due to the level of expression of the flt-1-VEGF receptor that is down-regulated in KS cells as compared with endothelial cells. KS-derived bFGF and VEGF synergize in inducing endothelial cell growth as shown by studies using both neutralizing antibodies and antisense oligodeoxynucleotides directed against these cytokines. In addition, VEGF and bFGF synergize to induce angiogenic KS-like lesions in nude mice and vascular permeability and edema in guinea pigs. These results indicate that inflammatory cytokines present in KS lesions stimulate the production of bFGF and VEGF, which, in turn, cooperate to induce angiogenesis, edema, and KS lesion formation.

Full text

PDF
1433

Images in this article

1437Figure 1
on p.1437
1438Figure 3
on p.1438

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboulafia D., Miles S. A., Saks S. R., Mitsuyasu R. T. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr. 1989;2(1):54–58. [PubMed] [Google Scholar]
  2. Barillari G., Buonaguro L., Fiorelli V., Hoffman J., Michaels F., Gallo R. C., Ensoli B. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol. 1992 Dec 1;149(11):3727–3734. [PubMed] [Google Scholar]
  3. Blood A. J., Toga A. W. Optical intrinsic signal imaging responses are modulated in rodent somatosensory cortex during simultaneous whisker and forelimb stimulation. J Cereb Blood Flow Metab. 1998 Sep;18(9):968–977. doi: 10.1097/00004647-199809000-00006. [DOI] [PubMed] [Google Scholar]
  4. Brown L. F., Tognazzi K., Dvorak H. F., Harrist T. J. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol. 1996 Apr;148(4):1065–1074. [PMC free article] [PubMed] [Google Scholar]
  5. Brown L. F., Yeo K. T., Berse B., Yeo T. K., Senger D. R., Dvorak H. F., van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med. 1992 Nov 1;176(5):1375–1379. doi: 10.1084/jem.176.5.1375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cai J., Gill P. S., Masood R., Chandrasoma P., Jung B., Law R. E., Radka S. F. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol. 1994 Jul;145(1):74–79. [PMC free article] [PubMed] [Google Scholar]
  7. Cornali E., Zietz C., Benelli R., Weninger W., Masiello L., Breier G., Tschachler E., Albini A., Stürzl M. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol. 1996 Dec;149(6):1851–1869. [PMC free article] [PubMed] [Google Scholar]
  8. De Paoli P., Caffau C., D'Andrea M., Tavio M., Tirelli U., Santini G. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma. J Acquir Immune Defic Syndr. 1994 Jul;7(7):695–699. [PubMed] [Google Scholar]
  9. Detmar M., Brown L. F., Claffey K. P., Yeo K. T., Kocher O., Jackman R. W., Berse B., Dvorak H. F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994 Sep 1;180(3):1141–1146. doi: 10.1084/jem.180.3.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 1990 May 3;345(6270):84–86. doi: 10.1038/345084a0. [DOI] [PubMed] [Google Scholar]
  11. Ensoli B., Gallo R. C. AIDS-associated Kaposi's sarcoma: a new perspective of its pathogenesis and treatment. Proc Assoc Am Physicians. 1995 Apr;107(1):8–18. [PubMed] [Google Scholar]
  12. Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M., Cafaro A., Chang H. K., Brady J. N., Gallo R. C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 1994 Oct 20;371(6499):674–680. doi: 10.1038/371674a0. [DOI] [PubMed] [Google Scholar]
  13. Ensoli B., Markham P., Kao V., Barillari G., Fiorelli V., Gendelman R., Raffeld M., Zon G., Gallo R. C. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J Clin Invest. 1994 Nov;94(5):1736–1746. doi: 10.1172/JCI117521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ensoli B., Nakamura S., Salahuddin S. Z., Biberfeld P., Larsson L., Beaver B., Wong-Staal F., Gallo R. C. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science. 1989 Jan 13;243(4888):223–226. doi: 10.1126/science.2643161. [DOI] [PubMed] [Google Scholar]
  15. Fan J., Bass H. Z., Fahey J. L. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol. 1993 Nov 1;151(9):5031–5040. [PubMed] [Google Scholar]
  16. Fiorelli V., Gendelman R., Samaniego F., Markham P. D., Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest. 1995 Apr;95(4):1723–1734. doi: 10.1172/JCI117849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fiorelli V., Gendelman R., Sirianni M. C., Chang H. K., Colombini S., Markham P. D., Monini P., Sonnabend J., Pintus A., Gallo R. C. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood. 1998 Feb 1;91(3):956–967. [PubMed] [Google Scholar]
  18. Frank S., Hübner G., Breier G., Longaker M. T., Greenhalgh D. G., Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem. 1995 May 26;270(21):12607–12613. doi: 10.1074/jbc.270.21.12607. [DOI] [PubMed] [Google Scholar]
  19. Goto F., Goto K., Weindel K., Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest. 1993 Nov;69(5):508–517. [PubMed] [Google Scholar]
  20. Haverkos H. W., Drotman D. P. Prevalence of Kaposi's sarcoma among patients with AIDS. N Engl J Med. 1985 Jun 6;312(23):1518–1518. [PubMed] [Google Scholar]
  21. Hober D., Haque A., Wattre P., Beaucaire G., Mouton Y., Capron A. Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin Exp Immunol. 1989 Dec;78(3):329–333. [PMC free article] [PubMed] [Google Scholar]
  22. Houck K. A., Ferrara N., Winer J., Cachianes G., Li B., Leung D. W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 1991 Dec;5(12):1806–1814. doi: 10.1210/mend-5-12-1806. [DOI] [PubMed] [Google Scholar]
  23. Houck K. A., Leung D. W., Rowland A. M., Winer J., Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992 Dec 25;267(36):26031–26037. [PubMed] [Google Scholar]
  24. Jaffe H. W., Choi K., Thomas P. A., Haverkos H. W., Auerbach D. M., Guinan M. E., Rogers M. F., Spira T. J., Darrow W. W., Kramer M. A. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med. 1983 Aug;99(2):145–151. doi: 10.7326/0003-4819-99-2-145. [DOI] [PubMed] [Google Scholar]
  25. Kim K. J., Li B., Houck K., Winer J., Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors. 1992;7(1):53–64. doi: 10.3109/08977199209023937. [DOI] [PubMed] [Google Scholar]
  26. Krigel R. L., Odajnyk C. M., Laubenstein L. J., Ostreicher R., Wernz J., Vilcek J., Rubinstein P., Friedman-Kien A. E. Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma. J Biol Response Mod. 1985 Aug;4(4):358–364. [PubMed] [Google Scholar]
  27. Krigel R. L., Padavic-Shaller K. A., Rudolph A. R., Poiesz B. J., Comis R. L. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study. J Biol Response Mod. 1989 Aug;8(4):359–365. [PubMed] [Google Scholar]
  28. Lepe-Zuniga J. L., Mansell P. W., Hersh E. M. Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol. 1987 Sep;25(9):1695–1700. doi: 10.1128/jcm.25.9.1695-1700.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Masood R., Cai J., Zheng T., Smith D. L., Naidu Y., Gill P. S. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):979–984. doi: 10.1073/pnas.94.3.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McNutt N. S., Fletcher V., Conant M. A. Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am J Pathol. 1983 Apr;111(1):62–77. [PMC free article] [PubMed] [Google Scholar]
  31. Miles S. A., Martínez-Maza O., Rezai A., Magpantay L., Kishimoto T., Nakamura S., Radka S. F., Linsley P. S. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science. 1992 Mar 13;255(5050):1432–1434. doi: 10.1126/science.1542793. [DOI] [PubMed] [Google Scholar]
  32. Millauer B., Shawver L. K., Plate K. H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 1994 Feb 10;367(6463):576–579. doi: 10.1038/367576a0. [DOI] [PubMed] [Google Scholar]
  33. Mitsuyasu R. T. Clinical aspects of AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1993 Sep;5(5):835–844. doi: 10.1097/00001622-199309000-00011. [DOI] [PubMed] [Google Scholar]
  34. Moore P. S., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995 May 4;332(18):1181–1185. doi: 10.1056/NEJM199505043321801. [DOI] [PubMed] [Google Scholar]
  35. Nakamura S., Murakami-Mori K., Rao N., Weich H. A., Rajeev B. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. J Immunol. 1997 May 15;158(10):4992–5001. [PubMed] [Google Scholar]
  36. Pepper M. S., Ferrara N., Orci L., Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun. 1992 Dec 15;189(2):824–831. doi: 10.1016/0006-291x(92)92277-5. [DOI] [PubMed] [Google Scholar]
  37. Regezi J. A., MacPhail L. A., Daniels T. E., DeSouza Y. G., Greenspan J. S., Greenspan D. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. Am J Pathol. 1993 Jul;143(1):240–249. [PMC free article] [PubMed] [Google Scholar]
  38. Ruszczak Z., Mayer da Silva A., Orfanos C. E. Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma. Dermatologica. 1987;175(6):270–279. doi: 10.1159/000248833. [DOI] [PubMed] [Google Scholar]
  39. Ruszczak Z., Mayer-Da Silva A., Orfanos C. E. Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol. 1987 Oct;9(5):388–398. [PubMed] [Google Scholar]
  40. Safai B., Johnson K. G., Myskowski P. L., Koziner B., Yang S. Y., Cunningham-Rundles S., Godbold J. H., Dupont B. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):744–750. doi: 10.7326/0003-4819-103-5-744. [DOI] [PubMed] [Google Scholar]
  41. Samaniego F., Markham P. D., Gallo R. C., Ensoli B. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol. 1995 Apr 1;154(7):3582–3592. [PubMed] [Google Scholar]
  42. Samaniego F., Markham P. D., Gendelman R., Gallo R. C., Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol. 1997 Feb 15;158(4):1887–1894. [PubMed] [Google Scholar]
  43. Schlesinger M., Chu F. N., Badamchian M., Jiang J. D., Roboz J. P., Goldstein A. L., Bekesi J. G. A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals. Clin Immunol Immunopathol. 1994 Nov;73(2):252–260. doi: 10.1006/clin.1994.1195. [DOI] [PubMed] [Google Scholar]
  44. Sirianni M. C., Vincenzi L., Fiorelli V., Topino S., Scala E., Uccini S., Angeloni A., Faggioni A., Cerimele D., Cottoni F. gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood. 1998 Feb 1;91(3):968–976. [PubMed] [Google Scholar]
  45. Stürzl M., Brandstetter H., Zietz C., Eisenburg B., Raivich G., Gearing D. P., Brockmeyer N. H., Hofschneider P. H. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene. 1995 May 18;10(10):2007–2016. [PubMed] [Google Scholar]
  46. Tsai J. C., Goldman C. K., Gillespie G. Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg. 1995 May;82(5):864–873. doi: 10.3171/jns.1995.82.5.0864. [DOI] [PubMed] [Google Scholar]
  47. Vyakarnam A., Matear P., Meager A., Kelly G., Stanley B., Weller I., Beverley P. Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin Exp Immunol. 1991 Apr;84(1):109–115. doi: 10.1111/j.1365-2249.1991.tb08132.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wangoo A., Taylor I. K., Haynes A. R., Shaw R. J. Up-regulation of alveolar macrophage platelet-derived growth factor-B (PDGF-B) mRNA by interferon-gamma from Mycobacterium tuberculosis antigen (PPD)-stimulated lymphocytes. Clin Exp Immunol. 1993 Oct;94(1):43–50. doi: 10.1111/j.1365-2249.1993.tb05975.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weindel K., Marmé D., Weich H. A. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun. 1992 Mar 31;183(3):1167–1174. doi: 10.1016/s0006-291x(05)80313-4. [DOI] [PubMed] [Google Scholar]
  50. Xerri L., Hassoun J., Planche J., Guigou V., Grob J. J., Parc P., Birnbaum D., deLapeyriere O. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am J Pathol. 1991 Jan;138(1):9–15. [PMC free article] [PubMed] [Google Scholar]
  51. Zhang Y. M., Bachmann S., Hemmer C., van Lunzen J., von Stemm A., Kern P., Dietrich M., Ziegler R., Waldherr R., Nawroth P. P. Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol. 1994 Jan;144(1):51–59. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES